Stockscreener 앱 받기
2.15
1.83%
-0.04
시간 외 거래:
2.14
-0.010
-0.47%
Lipella Pharmaceuticals Inc 주식(LIPO)의 최신 뉴스
Spartan Capital Securities, LLC Proudly Serves as the Sole Agent in Lipella Pharmaceuticals Inc. - Ukraine Business Journal
Spartan Capital Securities, LLC Announces Key February Transactions - The Manila Times
Spartan Capital Securities, LLC Announces Key February Transactions - GlobeNewswire Inc.
Lipella Pharmaceuticals stock hits 52-week low at $2.21 - Investing.com India
Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.'s $3,788,000 Private Placement - The Manila Times
Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.’s $3,788,000 Private Placement - Yahoo Finance
Lipella Pharmaceuticals (LIPO) Expected to Announce Earnings on Tuesday - Defense World
FDA approves Lipella's oral treatment access program - MSN
Lipella Pharmaceuticals modifies agreement with Spartan Capital By Investing.com - Investing.com South Africa
Lipella Pharmaceuticals modifies agreement with Spartan Capital - Investing.com
With New Data, Lipella Plots 2025 Milestones For Oral Rinse Tacrolimus - News & Insights
Analyzing Lipella Pharmaceuticals (NASDAQ:LIPO) and IDEAYA Biosciences (NASDAQ:IDYA) - Defense World
Lipella Pharmaceuticals Gains Buy Rating from Jason McCarthy Following Positive Phase 2a Results for LP-310 - TipRanks
3 Penny Stocks to Watch Now, 2/13/25 - TipRanks
Lipella Pharmaceuticals Announces Positive Phase 2a Results for LP-310 in Oral Lichen Planus Treatment - Defense World
Biotech Rips On Topline Analysis - The Globe and Mail
Nano Cap Lipella Pharmaceuticals Stock Jumps On Positive Trial Data In Patients With Sore Mouth Membranes - AOL
Lipella Pharmaceuticals Reports Positive Topline Phase 2a Results for LP-310 in the Treatment of Oral Lichen Planus - GlobeNewswire
Lipella Pharmaceuticals Shares Rise After Positive Phase 2a Trial Results for Oral Lichen Planus Treatment - Marketscreener.com
Stock market news: Firefly Neuroscience +214.56%, Dominari Holdings +37.66% among top gainers during midday trading - Business Upturn
Stock market today: Firefly Neuroscience +60.32%, Dominari Holdings +36.36% among top gainers in early trading - Business Upturn
Lipella Pharmaceuticals Gains FDA Approval for LP-310 - TipRanks
Lipella Pharmaceuticals (LIPO) Stock Soars In Pre-Hour Session - Stocks Telegraph
Clinical Trials News Live Feed - StockTitan
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
How Did Markets React to the Latest Round of Tariff Announcements? - The Globe and Mail
Clinical Trial Success: Lipella's LP-310 Slashes Pain Scores by 64% in Oral Disease Study - StockTitan
Top Small Cap Stocks To Watch NowFebruary 06th - MarketBeat
Lipella Pharmaceuticals Inc (LIPO) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle
Taking on analysts’ expectations and winning: Lipella Pharmaceuticals Inc (LIPO) - SETE News
These 5 Health Care Stocks Saw The Sharpest Retail Interest Jump Last Week - Asianet Newsable
Analyzing the Price-to-Earnings Ratio of Lipella Pharmaceuticals Inc (LIPO) - The News Heater
🔬 Latest pharma industry updates 👇 - substack.com
Stock summary: Lipella Pharmaceuticals posted weekly surge of 13.70% as it got FDA approval for an expanded access program - Business Upturn
LIPO Stock Sees Surge of Approximately 74.16% in Last Five Days - Knox Daily
Is Lipella Pharmaceuticals Inc (NASDAQ:LIPO) stock a better investment at this time? - US Post News
Lipella Pharmaceuticals Receives Buy Rating Amidst Promising FDA Approval and Strategic Financial Moves - TipRanks
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Lipella Pharmaceuticals Inc [LIPO] Revenue clocked in at $0.48 million, up 52.46% YTD: What’s Next? - The DBT News
FDA approves Lipella’s oral treatment access program By Investing.com - Investing.com Nigeria
Lipella Pharmaceuticals skyrockets on FDA access approval for mouth disease treatment - Mugglehead
United States shares mixed at close of trade; Dow Jones Industrial Average down 0.28% - Investing.com India
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.28% - Investing.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Offerings News Live Feed - StockTitan
Stock market news: Lipella Pharmaceuticals +96.90%, Digital Turbine +66.19% among top gainers as investors assess corporate earnings report - Business Upturn
Stock market news: Lottery.com surged by 93.55% while Lipella Pharmaceuticals posted rise of 86.44% during mid day trading - Business Upturn
Strong Earnings Drive Digital Turbine (APPS) Stock’s Market Rally - Stocks Telegraph
Dow Dips 150 Points; Bristol Myers Squibb Issues Weak Outlook - Benzinga
Acquisition Announcement Propels Altus Power (AMPS) Shares Upward - Stocks Telegraph
Stock market today: Lipella Pharmaceuticals jumped by 98.06% whereas ReTo Eco-Solutions plunged by 38.75% in early trading - Business Upturn
Stock market today: Lipella Pharmaceuticals +99.22%, Digital Turbine +68.90% among top gainers in early trading - Business Upturn
Dow Edges Higher; US Weekly Jobless Claims Increase - Benzinga
FDA Greenlight Sends Lipella Pharma Stock Skyrocketing 160% - Wall Street Pit
Lipella Pharmaceuticals (LIPO) Stock Sees Strong Pre-Market Rally - Stocks Telegraph
Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for LP-310 in Oral Lichen Planus - GlobeNewswire
Revolutionary Oral Disease Treatment Gets FDA Early Access Approval6M Americans Could Benefit - StockTitan
0.57%
자본화:
|
볼륨(24시간):